Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions

被引:17
作者
Li, LXL [1 ]
Crotty, KA
Palmer, AA
Scolyer, RA
Thompson, RA
McCarthy, SW
机构
[1] Royal Prince Alfred Hosp, Melanoma & Skin Canc Res Inst, Camperdown, NSW 2050, Australia
[2] Royal Prince Alfred Hosp, Sydney Melanoma Unit, Camperdown, NSW 2050, Australia
[3] Royal Prince Alfred Hosp, Dept Anat Pathol, Camperdown, NSW 2050, Australia
[4] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia
[5] Univ Sydney, Dept Surg, Sydney, NSW 2006, Australia
[6] Concord Hosp, Ctr Educ & Res Ageing, Concord, NSW, Australia
关键词
argyrophilic staining of nucleolar organizer region; (AgNOR); count; morphometry; melanocytic lesion; melanoma; nevi; Spitz nevi;
D O I
10.1097/00000372-200306000-00002
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Differentiation between malignant melanomas (MMs) and benign nevi based on histologic features can sometimes be difficult. This study evaluated the diagnostic effectiveness of argyrophilic staining of nucleolar organizer regions (AgNORs) in separating benign nevi from MMs by assessing 27 compound nevi (CN), 20 dysplastic nevi (DN), 10 Spitz nevi (SN), and 24 MMs. Both AgNOR count and morphology variables were measured from the superficial, middle, and deep zones of the lesions using video image analysis. Malignant melanomas had a significantly greater AgNOR number per nucleus, mean AgNOR area per nucleus, and variation in AgNOR area per nucleus compared with all types of benign nevi (p < 0.05). In multivariate, discriminant analysis using a combination of four AgNOR counts and morphometric parameters, all CN and DN, 8 of 10 SN, and 23 of 24 MMs could be correctly classified as benign or malignant. The results suggest that both AgNOR count and morphology help to separate benign and malignant melanocytic lesions and that the combination of both sets of parameters improves their discriminating ability.
引用
收藏
页码:190 / 197
页数:8
相关论文
共 51 条
[1]   Silver-stained nucleolar organizer regions (AgNORs) as a prognostic value in malignant melanoma [J].
Barzilai, A ;
Goldberg, I ;
Yulash, M ;
Pavlotsky, F ;
Zuckerman, A ;
Trau, H ;
Azizi, E ;
Kopolovic, J .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1998, 20 (05) :473-477
[2]  
Canet V, 2001, CYTOMETRY, V43, P110, DOI 10.1002/1097-0320(20010201)43:2<110::AID-CYTO1025>3.0.CO
[3]  
2-7
[4]   CORRELATION OF NUCLEOLAR ORGANIZER REGIONS AND NUCLEAR MORPHOMETRY ASSESSED BY AUTOMATIC IMAGE-ANALYSIS IN BREAST-CANCER WITH ANEUPLOIDY, K167 IMMUNOSTAINING, HISTOPATHOLOGIC GRADE AND LYMPH-NODE INVOLVEMENT [J].
CHARPIN, C ;
BONNIER, P ;
PIANA, L ;
KOUZHAMI, H ;
DEVICTOR, B ;
LAVAUT, MN ;
ANDRAC, L ;
ALLASIA, C .
PATHOLOGY RESEARCH AND PRACTICE, 1992, 188 (08) :1009-1017
[5]   IMPROVED SILVER STAINING OF NUCLEOLAR ORGANIZER REGIONS IN PARAFFIN WAX SECTIONS USING AN INVERTED INCUBATION TECHNIQUE [J].
COGHILL, G ;
GRANT, A ;
ORRELL, JM ;
JANKOWSKI, J ;
EVANS, AT .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (12) :1029-1031
[6]   CORRELATION BETWEEN NOR SIZES AND NUMBERS IN NON-HODGKINS LYMPHOMAS [J].
CROCKER, J ;
EGAN, MJ .
JOURNAL OF PATHOLOGY, 1988, 156 (03) :233-239
[7]   NUCLEOLAR ORGANIZER REGION ASSOCIATED PROTEINS IN CUTANEOUS MELANOTIC LESIONS - A QUANTITATIVE STUDY [J].
CROCKER, J ;
SKILBECK, N .
JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (08) :885-889
[8]   HOW SHOULD WE COUNT AGNORS - PROPOSALS FOR A STANDARDIZED APPROACH [J].
CROCKER, J ;
BOLDY, DAR ;
EGAN, MJ .
JOURNAL OF PATHOLOGY, 1989, 158 (03) :185-188
[9]   NUCLEOLAR ORGANIZER REGIONS IN LYMPHOMAS [J].
CROCKER, J ;
NAR, P .
JOURNAL OF PATHOLOGY, 1987, 151 (02) :111-118
[10]  
CROCKER J, 1993, PROLIFERATION LYMPHO, P145